Background: Despite recent advances in interventional equipment and techniques, the
angiographic no-reflow phenomenon occurs in a considerable number of patients …

Aim To evaluate the association between the preprocedural hemoglobin (Hb) level and 1
year major adverse cardiac event (MACE) in patients undergoing percutaneous coronary …

Objective: Diabetes mellitus, a common metabolic disorder, is often associated with severe
coronary artery disease. In this study, we compared the angiographic severity of coronary …

Background For all the wealth of research comparing the efficacy of the different types of the
drug-eluting stent (DES) such as sirolimus-, paclitaxel-, and zotarolimus-eluting stents, there …

Objectives: New-generation coronary stents including zotarolimus-and everolimus-eluting
stents (ZES and EES) have been shown to decrease the risk of restenosis. The purpose of …

Background: Studies have shown controversial effects of obesity on major adverse cardiac
events (MACE) after percutaneous coronary intervention (PCI). We sought to investigate the …

On-Label and Off-Label Use of Drug-Eluting Stents - PMC Back to Top Skip to main content NIH
NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation …

This study was designed to compare the blood lipid profile and conventional cardiovascular
risk factors in patients with acute coronary syndrome (ACS) and chronic stable angina …

BACKGROUND There is a lack of data in our society on the outcomes, complications, and
prognostic factors in patients with coronary artery disease who underwent percutaneous …